Quantcast
Last updated on April 18, 2014 at 1:21 EDT

Latest Robert Provenzano Stories

2014-04-02 23:02:04

Dr. Rubin to Lead Saint Luke's Kidney Transplant Program Kansas City, MO (PRWEB) April 02, 2014 Mario F. Rubin, M.D., has joined Saint Luke’s Hospital as chief of nephrology and medical director of the Kidney Transplant Program. Dr. Rubin will lead a highly experienced team of nephrologists and transplant specialists who since 1969 have performed more than 1,400 kidney transplants. “Dr. Rubin brings to Saint Luke’s Kidney Transplant Program a wealth of experience and knowledge,...

2014-02-26 08:25:10

SEATTLE, Feb. 26, 2014 /PRNewswire/ -- Northwest Kidney Centers is pleased to announce that its president and chief executive officer, Joyce F. Jackson, was one of two people named Outstanding Health Care Executive of the year by Seattle Business magazine. Jackson received the honor at the magazine's annual Leaders in Health Care Awards ceremony held Feb. 24 at the Washington State Convention Center. (Photo: http://photos.prnewswire.com/prnh/20140226/PH72079 ) In a tie decision by...

2014-02-21 11:38:00

Efforts to reduce these harms may safeguard patients' health In addition to experiencing negative health effects from their disease, patients with chronic kidney disease (CKD) are also at risk of experiencing hazardous events potentially related to medical treatments they receive. A study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN) finds that low blood sugar and high blood potassium being common complications of their medical care. Patients...

2014-02-19 12:28:30

ATLANTA, Feb. 19, 2014 /PRNewswire/ -- On Monday, February 10, 2014, Affiliated Dialysis Centers, LLC ("ADC") shared its first release of clinical data at the 2014 34(th) Annual Dialysis Conference in Atlanta, GA. Since 2013, ADC has engaged Xelay Acumen, a strategy and medical data analytics firm, to independently lead its data collection and analysis effort. Dr. Alex Yang MD presented the initial results from this health outcomes clinical research study involving ESRD patients who...

2014-01-28 12:29:43

New Alternative for DC Residents Seeking Transplant WASHINGTON, Jan 28, 2014 /PRNewswire-USNewswire/ -- The George Washington University Hospital is pleased to announce that a District of Columbia administrative law judge has given the hospital permission to initiate a kidney and pancreas transplant program. This decision now opens the doors to people in the District of Columbia to have the opportunity to receive treatment for kidney and pancreatic diseases at The George Washington...

2014-01-24 11:33:02

Patients with sickle cell trait require more anemia drugs The presence of sickle cell trait among African Americans may help explain why those on dialysis require higher doses of an anemia medication than patients of other ethnicities, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN). Additional studies are needed to determine the long-term health consequences of this increased dosing. Sickle cell trait represents the...

2014-01-21 23:01:30

Brian Radbill, MD, FACP, a 15-year veteran of the Mount Sinai Health System, has been named Chief Medical Officer and Vice President of Medical Affairs for Mount Sinai Queens. New York, NY (PRWEB) January 21, 2014 Brian Radbill, MD, FACP, a 15-year veteran of the Mount Sinai Health System, has been named Chief Medical Officer and Vice President of Medical Affairs for Mount Sinai Queens. In that position, Dr. Radbill will oversee the delivery of high-quality, patient-focused medical care...

2014-01-10 16:21:55

DUBLIN, January 10, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/j635wj/nephrology_and) has announced the addition of the "2013 Report on the International Nephrology and Urology Devices Market - Industry Analysis, Size, Share, Trends and Forecast to 2018" [http://www.researchandmarkets.com/research/j635wj/nephrology_and ] report to their offering. <start_newscom> (Logo: http://photos.prnewswire.com/prnh/20130307/600769 )...

2014-01-08 23:24:51

Proprietary Renal Nutrition Supplement Approved Philadelphia, PA (PRWEB) January 08, 2014 In a move to expand its geographic reach to international markets and further implement the strategic growth plan of the company, Pentec Health, Inc. today announced that it has been awarded a patent by the Intellectual Property Office of Australia for its specialty pharmacy compounded prescription renal formulation, PROPLETE®. Proplete® is a proprietary Intradialytic Parenteral Nutrition...

2013-12-17 11:14:47

Patients with stable hypertension and the most advanced stage of chronic kidney disease (CKD) before dialysis appeared to have a lower risk for long-term dialysis or death if they were treated with the antihypertensive drugs known as angiotensin-converting enzyme inhibitors (ACEIs) or angiotensin II receptor blockers (ARBs), according to a study published by JAMA Internal Medicine, a JAMA Network publication. An ACEI or ARB is known to delay the progression of CKD in patients with and...